Electrophoresis Reagents Global Market Report 2024

The global electrophoresis reagents market has grown strongly in recent years. It will grow from $1.26 billion in 2023 to $1.34 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. Historical growth can be attributed to heightened demand for clinical diagnostics, the introduction of innovative reagents, the proliferation of academic and research institutions, advancements in clinical research and biomarker discovery, and the expansion of global markets.

The global electrophoresis reagents market is expected to see strong growth in the next few years. It will grow to $1.76 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. During the forecast period, growth is driven by the expansion of point-of-care testing, the transition towards capillary electrophoresis, emphasis on sustainable reagent formulations, the increasing demand for high-throughput analysis, and advancements in microfluidic electrophoresis. Key trends anticipated in this period involve technological advancements in electrophoresis techniques, the adoption of next-generation sequencing (NGS), a continued demand for high-throughput techniques, strategic collaborations and partnerships within the industry, the integration of artificial intelligence (AI) in data analysis, and a focus on customization and compatibility in the field.

The rapid growth in the elderly population is poised to drive the expansion of the electrophoresis reagent market. This demographic, defined as individuals aged 60 and above, is increasingly reliant on hemoglobin electrophoresis for diagnosing anemia, sickle cell disease, and other hemoglobin disorders. According to the World Health Organization's October 2022 report, globally, one out of every six individuals will be 60 or older by 2030, and this age group is anticipated to double in size, reaching 2.1 billion by 2050. Additionally, data from the UK Parliament's House of Commons Library in June 2021 forecasts a rise in the UK's senior population, expected to encompass 24% of the total population (17.4 million people) by 2043. Hence, the rapidly expanding geriatric population fuels the growth of the electrophoresis reagent market.

The burgeoning demand within hospitals is expected to propel the electrophoresis reagents market. These healthcare institutions, known for providing diverse medical services, heavily rely on electrophoresis reagents for diagnostics, research, detection, monitoring of medical conditions, and advancing medical knowledge. According to Interweave Textiles Limited's August 2023 data, there are 1148 hospitals in the UK. The increasing number of hospitals signifies the surging need for effective diagnostic tools, further driving the demand for electrophoresis reagents.

Innovation in product development has emerged as a notable trend reshaping the electrophoresis reagents market. Key companies within the sector are focused on creating novel products to maintain their market standing. For instance, in February 2022, Kemira Oyj, a Finland-based chemical industry company, introduced biomass-balanced polyacrylamide. This polymer, possessing similar technical properties to its conventional counterpart, finds utility in various industries such as energy, demanding paper applications, water treatment, and other water-intensive sectors.

Significant players in the electrophoresis reagents market are prioritizing innovative products like XpressAmp to drive market revenues. XpressAmp direct amplification chemicals streamline sample preparation by eliminating the need for RNA extraction. For instance, in March 2021, Promega Corporation, a US-based biotechnology company, launched XpressAmp. This advancement enables laboratories conducting COVID-19 tests to skip the RNA extraction step, swiftly transitioning to polymerase chain reaction (PCR) amplification after a brief 10-minute incubation period at room temperature.

In July 2021, PerkinElmer, a renowned US-based biotechnology research corporation, concluded the acquisition of BioLegend for a significant sum of $5.25 billion. This strategic move stands as a transformative agreement for PerkinElmer, positioning the company to fortify its stance in the Life Sciences sector, expediting groundbreaking discoveries in precision medicine. BioLegend, headquartered in the US, specializes in the production of antibodies and reagents pivotal for biomedical research, specifically in the separation of macromolecules within samples. This acquisition amplifies PerkinElmer's capabilities, facilitating advancements in the field of precision medicine and reinforcing its role as an innovator in the life sciences arena.

Major companies operating in the electrophoresis reagents market report are Thermo Fisher Scientific Inc., Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Lonza Group Ltd., Takara Bio Inc., Sebia Group, The Merck Group, BioAtlas OU, Cytiva, Promega Corporation, Helena Laboratories Corporation, Randox Laboratories Limited, Apacor Limited, Qiagen NV, Hoefer Inc., VWR International GmbH, anamed Elektrophorese GmbH, Alfa Aesar, General Electric Company, Merck Millipore, GenScript Corp., Zymo Research Corp., Omega Bio-tek Inc., Norgen Biotek Corp., Eurofins Genomics LLC

North America was the largest region in the electrophoresis reagents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electrophoresis reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electrophoresis reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary constituents of electrophoresis reagents comprise gels (such as polyacrylamide, starch, and agarose), buffers (like TAE buffer, TBE buffer, and others), dyes (including ETBR, SYBR, bromophenol blue, and similar compounds), and additional supporting reagents. Gels, synthesized through free-radical polymerization of bis-acrylamide and acrylamide, form the matrix for electrophoretic separation, particularly polyacrylamide gels utilized in protein separation via gel electrophoresis. Electrophoresis techniques, namely capillary electrophoresis and gel electrophoresis, are employed for DNA and RNA analysis as well as protein analysis. End-users of these reagents span pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories, academic and research institutions, and various other entities involved in molecular analysis and research.

This report provides electrophoresis reagents market statistics, including electrophoresis reagents industry global market size, regional shares, competitors with an electrophoresis reagents market share, detailed electrophoresis reagents market segments, market trends and opportunities, and any further data you may need to thrive in the electrophoresis reagents industry. This electrophoresis reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electrophoresis reagents market consists of sales of electrophoresis reagents that are used for electrophoretic separation and sample analysis. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.